AzTrials
AzTrials

Healthy SubjectsEarly Phase 1NCT02643927

Efficacy of 8 vs 4 Sessions Mindfulness-based Programs in a Non-clinical Population

A Early Phase 1 study testing standard 8-weeks MBSR and 4-week shortened MBSR in people with Healthy Subjects, run by Hospital Miguel Servet.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study was to assess and compare the efficacy of a standard 8-weeks protocol based on the Mindfulness Based Stress Reduction MBSR program versus a 4-week shortened version of the protocol in the improvement of wellbeing variables in a non-clinical population in Spain. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Healthy Subjects
What is being tested?
standard 8-weeks MBSR and 4-week shortened MBSR
Could I receive a placebo?
No, everyone receives an active treatment
How many people
99 participants
Where
No sites listed yet
Study dates
Feb 2013to Oct 2013
Phase
Early Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • be adult (18-y or older);
  • willingness to participate in the study and signing informed consent;
  • ability to understand and write Spanish.

Who cannot join

  • have an acute clinical or psychiatry condition;
  • have no previous experience with mindfulness or other type of contemplative or mind-boy practices such as yoga, taichi or chikung.

About this study

Official title: Efficacy of 8 vs 4 Sessions Mindfulness-based Programs in a Non-clinical Population: a Controlled Study

The aim of this study was to assess and compare the efficacy of a standard 8-weeks protocol based on the Mindfulness Based Stress Reduction MBSR program versus a 4-week shortened version of the protocol in the improvement of wellbeing variables in a non-clinical population in Spain. The investigators initial hypothesis was that both protocols are efficacious but the standard 8-week performs better that the short one.

Being tested
standard 8-weeks MBSR, 4-week shortened MBSR

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • standard 8-weeks MBSRBehavioural

    A 8 weekly sessions of 120 min based on the standard protocol of Kabat Zinn was performed. The adapted program did not include a one-day retreat in silence, but one session in silence plus extra kindly awareness (compassion-based) and value-based exercises. Home practice was not systematically assessed, but recommended to be of 45min per day, most of the days. It was administered by a trained (3-y experience) and certified MBSR teacher (MMPD).

  • 4-week shortened MBSRBehavioural

    This protocol was made up of 4 sessions of 120 mn administered by the same trained MBSR programme therapist to avoid variables associated to the therapist. The rationale behind the shortened version of MBSR was to keep the core content and practices of the program, in fewer sessions: raisin exercise (experiential concept of mindfulness); and main anchors of attention (breathing, body sensations, body movements).

Study groups in NCT02643927
Study groupRoleWhat they receive
standard 8-weeks MBSRExperimental8-week program
Receives: Behavioral: standard 8-weeks MBSR
4-week shortened MBSRExperimentalShort 4 sessions intervention
Receives: Behavioral: 4-week shortened MBSR
Control GroupNo interventioncontrol group: No intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Hospital Anxiety and Depression Scale (HADS)

    Measured: baseline

  2. Hospital Anxiety and Depression Scale (HADS) change from baseline

    Measured: post-treatment 8 weeks from baseline in 8 weeks intervention group

  3. Hospital Anxiety and Depression Scale (HADS) change from baseline

    Measured: post-treatment 4 weeks from baseline in 4 weeks intervention group

  4. Hospital Anxiety and Depression Scale (HADS) change from baseline

    Measured: six-months follow-up

Secondary outcomes (5)
  1. Mindful Attention Awareness Scale (MAAS)

    Measured: baseline, post-treatment 8 weeks from baseline in 8 weeks intervention group, post-treatment 4 weeks from baseline in 4 weeks intervention group, and six-months follow-up

  2. Five Facets Mindfulness Questionnaire (FFMQ)

    Measured: baseline, post-treatment 8 weeks from baseline in 8 weeks intervention group, post-treatment 4 weeks from baseline in 4 weeks intervention group, and six-months follow-up

  3. Self-Compassion Scale (SCS)

    Measured: baseline, post-treatment 8 weeks from baseline in 8 weeks intervention group, post-treatment 4 weeks from baseline in 4 weeks intervention group, and six-months follow-up

  4. The Positive and Negative Affect Scale (PANAS)

    Measured: baseline, post-treatment 8 weeks from baseline in 8 weeks intervention group, post-treatment 4 weeks from baseline in 4 weeks intervention group, and six-months follow-up

  5. Connor-Davidson Resilience Scale (10-item CD-RISC)

    Measured: baseline, post-treatment 8 weeks from baseline in 8 weeks intervention group, post-treatment 4 weeks from baseline in 4 weeks intervention group, and six-months follow-up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Dec 2015 (estimated)
  2. Study startFeb 2013
  3. Primary completionApr 2013
  4. Study completionOct 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Early Phase 1
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
99 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02643927
Sponsor's protocol ID
PI12/00134
Status last verified
Dec 2015
First submitted
18 Dec 2015
Last updated
1 Jan 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Publications

  • Demarzo M, Montero-Marin J, Puebla-Guedea M, Navarro-Gil M, Herrera-Mercadal P, Moreno-Gonzalez S, Calvo-Carrion S, Bafaluy-Franch L, Garcia-Campayo J. Efficacy of 8- and 4-Session Mindfulness-Based Interventions in a Non-clinical Population: A Controlled Study. Front Psychol. 2017 Aug 8;8:1343. doi: 10.3389/fpsyg.2017.01343. eCollection 2017.

    PubMed 28848465

Questions about this trial

What is this clinical trial studying?

A Early Phase 1 study testing standard 8-weeks MBSR and 4-week shortened MBSR in people with Healthy Subjects, run by Hospital Miguel Servet.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jan 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Early Phase 1 (sometimes called Phase 0) studies give a very small amount of a treatment to a few people, mainly to see how the body handles it.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Hospital Anxiety and Depression Scale (HADS) (time frame: baseline). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02643927, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jan 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in